Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® C. Difficile specialty page provides c. difficile-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Using UV Light to Fight <i>C. difficile</i> in Hospitals
As hospitals continue to search for new ways to limit their number of patients acquiring Clostridium difficile (C. difficile) infections, a new study shows promise in the use of ultraviolet light technology for ridding patient rooms of highly resistant C. difficile spores.
Nursing Homes Receive New Rules on Antibiotic Stewardship
With the use of antibiotics remaining high and steady in American hospitals and healthcare facilities, new rules on infection prevention and antibiotic use are set to bring changes to thousands of nursing homes, nationwide.
New Study Shows High <em>C. difficile</em> Rates in Many US Hospitals
Consumer Reports recently evaluated more than 3,100 hospitals in the United States and found that about a third of them received a low rating for controlling infections from Clostridium difficile. 
Consuming High Levels of Zinc Could Make You Susceptible to <i>C. Difficile</i>
According to newly published research, high levels of zinc changes microbiota in the gut decreasing resistance to infections from Clostridium difficile.
Doctors Discover New Treatment for “Superbug” <em>C. difficile</em>
As so-called “superbug” bacteria continue to develop new ways of resisting antibiotics, scientists are on the search for new and alternative treatments. Promising news from a recent study is now showing that we may be able to battle the most virulent strains of the Clostridium difficile bacteria with a class of drugs already on the market.
Canadian Health Agency Releases 2016 Report on Antibiotic-resistant Bacteria
When the colistin-resistant gene, mcr-1, was first found in China in 2015, health officials around the world knew that the gene would inevitably appear in their countries. It has since been detected in other parts of Asia, Europe, and North America, including Canada, which just released a 2016 report from their Canadian Antimicrobial Resistance Surveillance System.
FDA Grants QIDP Designation to MGB-BP-3 to Treat <i>Clostridium difficile</i>-associated Diarrhea
The FDA has granted biopharmaceutical company, MGB Biopharma’s lead candidate, MGB-BP-3, Qualified Infectious Disease Product (QIDP) designation for the treatment of Clostridium difficile-associated Diarrhea.
Screening and Isolation of <em>C. difficile</em> Carriers Can Lower Incidence of Infections
A new study shows that detecting and isolating Clostridium difficile carriers when they are admitted to hospitals can significantly reduce the incidence of new infections from the pathogen. 
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.